**Abstract**

**Objectives:** Cannabidiol (CBD), a non-psychotomimetic compound of *Cannabis sativa*, induced antidepressant like-effects in rodents tested in the forced swimming and olfactory bulbectomy models (Zanelati et al., 2010, Linge et al., Neuropharmacology, 2015). However, no study so far has investigated CBD effects in animal models with greater construct validity for depression, such as the learned helplessness and the Flinders Sensitive and Flinders Resistent Line (FSL/FRL). The present work aimed at investigating the acute effects of CBD in these models.

**Methods and Results:** *Experiment 1*. For the learned helplessness (LH) paradigm male Wistar rats were submitted to the pre-test (inescapable footshocks) and test (escapable shocks) sessions with a seven days interval. A single injection of CBD (10, 30 mg/Kg, ip), imipramine (15 mg/Kg, ip) or vehicle was given to rats either after pre-test or 1h before test. Another group received daily injections of imipramine (15 mg/Kg/day, ip), between the pre-test and test, as a positive control for the antidepressant effect.

*Experiment 2*. FSL and FRL animals received single injections of CBD (10 or 30 mg/Kg, ip), ketamine (10 mg/Kg, ip) or vehicle and were submitted to the forced swimming test (FST) 1h later.

**Results:** *Experiment 1*. Acute treatment with CBD (30 mg/Kg) immediately after the pretest, but not with imipramine, significantly reduced the number of escape failures during the test, an antidepressant-like effect similar to chronic treatment with imipramine (ANOVA, p\<0.05). *Experiment 2*. Single injection of CBD (30 mg/Kg, ip) reduced the immobility in FSL and FRL animals, similarly to ketamine (10 mg/Kg, ip) (ANOVA, p\<0.05).

**Conclusion:** Acute treatment with CBD is able to induce antidepressant-like effect in the learned helplessness and FSL/FRL models. These results reinforce the proposal that CBD could induce acute antidepressant effects in humans.
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